Abstract:Background: Artial fibrosis has been recognized as a typical pathological change in atrial fibrillation. Although present evidence suggests that microRNA-499-5p (miR-499-5p) plays an important role in the development of atrial fibrosis, the specific mechanism is not fully understood. Therefore, this study attempted to assess the influence of miR-499-5p on atrial fibroblasts and explore the potential molecular mechanism. Methods: Atrial fibroblasts from sprague dawley rat were respectively transfected with miR-499-5p mimic, miR-499-5p negative control and miR-499-5p inhibitor, atrial fibroblasts without any treatment were also established. Cell counting kit-8 assay and transwell assay were used to detect the proliferation and migration of atrial fibroblasts in each group. Expressions of miR-499-5p, TGF-β1, smad2, α-SMA, collagen-I and TGFβ-R1 in mRNA and protein level were subsequently detected via quantitative real-time polymerase chain reaction and western blot. Furthermore, the prediction of the binding sites of miR-499-5p and TGFβ-R1 was performed via the bioinformatics online software TargetScan and verified by dual luciferase reporter. Results: By utilizing miR-499-5p-transfected atrial fibroblasts model, expression of miR-499-5p in the miR-499-5p mimic group was upregulated, while it was downregulated in the miR-499-5p inhibitors group. Upregulated miR-499-5p expression led to to a significant decrease in the proliferative and migratory ability of cultured atrial fibroblasts, while downregulated miR-499-5p expression led to a significant increase in the proliferative and migratory ability of cultured atrial fibroblasts. Additionally, upregulated miR-499-5p expression made a significant rise in TGF-β1-induced mRNA and protein expression of TGF-β1, TGFβ-R1, smad2, α-SMA and collagen-I in atrial fibroblasts. Furthermore, results from the dual luciferase reporter conformed that miR-499-5p may repress TGFβ-R1 by binding the 3'UTR of TGFβ-R1 directly. Conclusions: miR-499-5p is able to inhibit the activation of transforming growth factor β-induced Smad2 signaling and eventually suppressed the proliferation, migration and invasion of atrial fibroblasts and collagen synthesis by targeting TGFβ-R1.

miR-27b-3p reduces muscle fibrosis during chronic skeletal muscle injury by targeting TGF-βR1/Smad pathway

MicroRNA-27a-3p Inhibits Lung and Skin Fibrosis of Systemic Sclerosis by Negatively Regulating SPP1.

Lipidomics and Single-Cell RNA Sequencing Reveal Lipid and Cell Dynamics of Porcine Glycerol-Injured Skeletal Muscle Regeneration Model

Mir-24 and Mir-122 Negatively Regulate the Transforming Growth Factor-β/Smad Signaling Pathway in Skeletal Muscle Fibrosis

Mir-146A-5p Acts As a Negative Regulator of TGF-β Signaling in Skeletal Muscle after Acute Contusion.

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway

Cardiac Fibroblast Mir‐27a May Function As an Endogenous Anti‐fibrotic by Negatively Regulating Early Growth Response Protein 3 (EGR3)

Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis

MicroRNA-27a-3p is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation

miR‐122‐5p negatively regulates the transforming growth factor‐β/Smad signaling pathway in skeletal muscle myogenesis

Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors

Interleukin-15 facilitates muscle regeneration through modulation of fibro/adipogenic progenitors

MiR-340-5p mitigates the proliferation and activation of fibroblast in lung fibrosis by targeting TGF-/p38/ATF1 signaling pathway

MicroRNA-21-5p mediates TGF-β-regulated fibrogenic activation of spinal fibroblasts and the formation of fibrotic scars after spinal cord injury

mir-22-3p/KLF6/MMP14 axis in fibro-adipogenic progenitors regulates fatty infiltration in muscle degeneration.

MicroRNA‑375 Prevents TGF‑β‑dependent Transdifferentiation of Lung Fibroblasts Via the MAP2K6/P38 Pathway

miR-136-5p/FZD4 axis is critical for Wnt signaling-mediated myogenesis and skeletal muscle regeneration

miR-29a is a potential protective factor for fibrogenesis in gluteal muscle contracture

MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling

MicroRNA-499-5p inhibits transforming growth factor-β1-induced Smad2 signaling pathway and suppresses fibroblast proliferation and collagen synthesis in rat by targeting TGFβ-R1